ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
NICE final guidance backs Pfizer's Lorviqua pharmatimes
May 13, 2020The National Institute for Health and Care Excellence (NICE) has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of lung cancer on the NHS.
Pharma Sources Insight January 2025
